trending Market Intelligence /marketintelligence/en/news-insights/trending/kXM_GT9eyxJKpvh7tjubbg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Perrigo gets FDA approval for over-the-counter equivalents to GSK's nicotine gum

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Perrigo gets FDA approval for over-the-counter equivalents to GSK's nicotine gum

Perrigo Co. PLC received approvals from the U.S. FDA for abbreviated new drug applications referencing GlaxoSmithKline PLC's Nicorette White Ice Mint Gum, a nicotine chewing gum.

These products will be packaged and marketed as store brands or retailers' own label brands to bring alternatives to the GSK product.

Annual sales of Nicorette White Ice Mint Gum for the 12 months ending November were $79 million.